Immunity to tuberculosis: a delicate balance between protection and pathology
- PMID: 10076912
- DOI: 10.1111/j.1574-695X.1999.tb01234.x
Immunity to tuberculosis: a delicate balance between protection and pathology
Abstract
The currently used tuberculosis (TB) vaccine (Bacillus Calmette-Guérin) does not consistently prevent pulmonary infection. Novel vaccine strategies require an in-depth characterization of the cellular and molecular mechanisms of antituberculous protection. This review summarizes relevant data obtained in animal models of TB infection. In mycobacterial infections, immunologically mediated protection is intrinsically associated with tissue damage in the form of granuloma formation. The implications of this finding for future vaccine design and evaluation are discussed.
Similar articles
-
Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research.Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11497-502. doi: 10.1073/pnas.201404898. Epub 2001 Sep 18. Proc Natl Acad Sci U S A. 2001. PMID: 11562492 Free PMC article. Clinical Trial.
-
[Delayed-type hypersensitivity and caseous necrosis in tuberculous granuloma. New ideas for the design of a new vaccine against human tuberculosis].Med Clin (Barc). 2000 Oct 21;115(13):503-9. doi: 10.1016/s0025-7753(00)71606-x. Med Clin (Barc). 2000. PMID: 11093873 Review. Spanish. No abstract available.
-
Mycobacterium tuberculosis infection and vaccine development.Tuberculosis (Edinb). 2016 May;98:30-41. doi: 10.1016/j.tube.2016.02.005. Epub 2016 Feb 27. Tuberculosis (Edinb). 2016. PMID: 27156616 Review.
-
Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.Mol Med Rep. 2015 Aug;12(2):3073-80. doi: 10.3892/mmr.2015.3770. Epub 2015 May 12. Mol Med Rep. 2015. PMID: 25962477
-
Trained innate immunity and resistance to Mycobacterium tuberculosis infection.Clin Microbiol Infect. 2019 Dec;25(12):1468-1472. doi: 10.1016/j.cmi.2019.02.015. Epub 2019 Feb 23. Clin Microbiol Infect. 2019. PMID: 30807849 Review.
Cited by
-
Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology.J Exp Med. 2001 Dec 17;194(12):1847-59. doi: 10.1084/jem.194.12.1847. J Exp Med. 2001. PMID: 11748285 Free PMC article.
-
Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia.Clin Vaccine Immunol. 2010 May;17(5):771-7. doi: 10.1128/CVI.00526-09. Epub 2010 Mar 17. Clin Vaccine Immunol. 2010. PMID: 20237198 Free PMC article.
-
CD137 differentially regulates innate and adaptive immunity against Mycobacterium tuberculosis.Immunol Cell Biol. 2012 Apr;90(4):449-56. doi: 10.1038/icb.2011.63. Epub 2011 Jul 12. Immunol Cell Biol. 2012. PMID: 21747409 Free PMC article.
-
The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex.Front Immunol. 2021 Jan 22;11:623119. doi: 10.3389/fimmu.2020.623119. eCollection 2020. Front Immunol. 2021. PMID: 33552087 Free PMC article. Review.
-
Mycobacterium bovis Bacillus Calmette-Guérin-Infected Dendritic Cells Induce TNF-α-Dependent Cell Cluster Formation That Promotes Bacterial Dissemination through an In Vitro Model of the Blood-Brain Barrier.J Immunol. 2021 Aug 15;207(4):1065-1077. doi: 10.4049/jimmunol.2001094. Epub 2021 Jul 28. J Immunol. 2021. PMID: 34321229 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical